LAURA WILLIS: Open Payments
NPI 1700503604 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 35 payments from 14 companies in 2025. Trend: 2023 $477 · 2024 $919 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98 |
| Novo Nordisk Inc | 5 | $84 |
| PFIZER INC. | 4 | $77 |
| Lilly USA, LLC | 4 | $61 |
| Astellas Pharma US Inc | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Seqirus USA Inc | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $18 |
Products named: JARDIANCE, Wegovy, Veozah, PREVNAR 20, Auvelity, The Cologuard Plus Collection Kit, NURTEC ODT, Ozempic.
Industry payments across TX — which companies pay providers there.
